2021
DOI: 10.3389/fendo.2021.613755
|View full text |Cite
|
Sign up to set email alerts
|

Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Abstract: BackgroundThe American Joint Committee on Cancer (AJCC) staging for pancreatic neuroendocrine neoplasms (PanNENs) based on the number of positive lymph nodes (PLNs) is the most widely accepted nodal staging system. New nodal staging schemes that take both the number of PLNs and the number of examined lymph nodes into consideration have emerged as useful prognostic tools. The aim of the current study was to determine the most effective nodal staging system, among the 8th edition AJCC N staging (or PLN staging),… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 24 publications
0
18
1
Order By: Relevance
“…When all lymph nodes examined were positive, the LNR value did not increase with the number of positive lymph nodes. When all lymph nodes examined were negative, LODDS values decreased with increasing number of negative lymph nodes (13). LODDS has unique value for risk stratification of node-negative patients, which is not available with LNR and 8th AJCC N staging systems (19).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…When all lymph nodes examined were positive, the LNR value did not increase with the number of positive lymph nodes. When all lymph nodes examined were negative, LODDS values decreased with increasing number of negative lymph nodes (13). LODDS has unique value for risk stratification of node-negative patients, which is not available with LNR and 8th AJCC N staging systems (19).…”
Section: Discussionmentioning
confidence: 99%
“…Log odds of positive lymph node (LODDS) use pathological nodal data to stratify patients for differences in survival, and LODDS can help clinicians identify high-risk patients regardless of whether they are node-positive or not (8). The 8th edition AJCC N staging system, LNR and LODDS three lymph node staging systems are gradually applied in pancreatic and bile duct cancers (8,13). However, there are no studies explore and compare the value of these lymph node staging systems in predicting the survival of ACs, and cannot provide a reference for lymph node staging in patients with ACs.…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally, lymph node status is based on positive lymph nodes (PLNs) regardless of the number of resected lymph nodes (RLNs) ( 17 ). At present, the lymph node ratio (LNR), defined as the ratio between the number of PLNs and RLNs, is increasingly recognized as a powerful prognostic tool for many cancers ( 18 , 19 ). The log odds of positive lymph nodes (LODDS) is the logarithm of the ratio of metastatic lymph nodes to negative lymph nodes (log (PLNs+0.5)/(RLNs-PLNs+0.5)) and can identify patients with highly homologous prognoses.…”
Section: Introductionmentioning
confidence: 99%
“…It also overcomes the shortcoming of the LNR regardless of the number of lymph nodes examined ( 20 ). Recently, LODDS staging was hypothesized to be a better predictor of survival in many cancers compared with LNR and PLN staging ( 18 , 21 ). Previously, LODDS was used to analyze the prognostic role of mesenteric lymph nodes (MLNs) involvements in AOC ( 22 ).…”
Section: Introductionmentioning
confidence: 99%
“…While the N stage system is reproducible, it may reduce the likelihood of stage migration which can misguide treatment practice. Some staging systems have been established, including the Total Number of Lymph Nodes Examined (TNLE), the number of Positive Lymph Nodes (PLN), Lymph Node Ratio (LNR), and Log ODDS of positive nodes (LODDS), in order to accurately describe lymph node status ( 9 , 10 ). However, researchers have attempted to develop alternative lymph node staging systems which more accurately predict survival for patients with a number of different cancers.…”
Section: Introductionmentioning
confidence: 99%